Many oncologists argue PSA can lead to over-treatment, as a test that finds elevated PSA may be indicative of other health conditions other than cancer, such as an enlarged or inflamed prostate. Even in men who undergo biopsies, a randomized trial of more than 162,000 cases found no cancer in most of those using the test..

As a result, about one in three prostate cancers are aggressive, the PSA was rapidly adopted after the US Food and Drug Administration approved it for screening in 1994. But its overuse has alarmed many doctors because it can lead to painful and unnecessary biopsies as well as over-diagnosis and over-treatment. Watch the video below to learn more.


https://www.youtube.com/watch?v=HLmjobewP6g